PMID: 26236730 Secondary BPC-157: eNOS / VEGFR2 NO System & VEGF-Mediated Angiogenesis BPC-157 (10mg) modulates the nitric oxide system through both eNOS and iNOS pathways, and upregulates VEGFR2 expression in endothelial cell models, supporting pro-angiogenic signaling cascades
The available research on other modified versions of GRF(1-29) report that the analog led to an increase in GH levels within 2 hours of administration, and the effects were consistent after daily administration for 16 weeks [17]
These gene products are responsible for a wide range of antioxidant, anti-inflammatory, cytoprotective, and detoxification functions and include catalase, superoxide dismutase (SOD)-3, heme oxygenase-1, glutathione-S-transferases, NAD(P)H-quinone oxidoreductase (NQO1), glutathione peroxidase, and glucuronosyltransferase-1a6 (UGT-1a6) [11]
No added preservatives
Each injection contains 600 mg of Glutathione and 500 mg of Vitamin C, both of which play vital roles in maintaining cellular health and combating oxidative stress